[Retracted] G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma

Table 1

Characteristics information table of HCC patients.

Characteristic	Low expression of GNG5	High expression of GNG5
	187	187
T stage, (%)			0.217
T1	99 (26.7%)	84 (22.6%)
T2	42 (11.3%)	53 (14.3%)
T3	39 (10.5%)	41 (11.1%)
T4	4 (1.1%)	9 (2.4%)
N stage, (%)			0.122
N0	127 (49.2%)	127 (49.2%)
N1	0 (0%)	4 (1.6%)
M stage, (%)			1.000
M0	132 (48.5%)	136 (50%)
M1	2 (0.7%)	2 (0.7%)
Pathologic stage, (%)			0.273
Stage I	96 (27.4%)	77 (22%)
Stage II	39 (11.1%)	48 (13.7%)
Stage III	39 (11.1%)	46 (13.1%)
Stage IV	2 (0.6%)	3 (0.9%)
Gender, (%)			0.047
Female	51 (13.6%)	70 (18.7%)
Male	136 (36.4%)	117 (31.3%)
Age, (%)			0.133
≤60	81 (21.7%)	96 (25.7%)
>60	106 (28.4%)	90 (24.1%)
Histologic grade, (%)			0.002
G1	35 (9.5%)	20 (5.4%)
G2	97 (26.3%)	81 (22%)
G3	51 (13.8%)	73 (19.8%)
G4	2 (0.5%)	10 (2.7%)